Association between CTLA-4 polymorphisms and the susceptibility to systemic lupus erythematosus and graves'disease in Thai population

Asian Pacific Journal of Allergy and Immunology

Volumn 29, Issue 3, 2011, Pages 229-235

  Kimkong, Ingorn ^a   Nakkuntod, Jeerawat ^b   Sae Ngow, Siriwalee ^b   Snabboon, Thiti ^b   Avihingsanon, Yingyos ^b   Hirankarn, Nattiya ^c  

^a KASETSART UNIVERSITY   (Thailand)

^b CHULALONGKORN UNIVERSITY   (Thailand)

^c CHULALONGKORN UNIVERSITY   (Thailand)

Author keywords

CTLA 4; Graves' disease; Polymorphisms; Systemic lupus erythematosus

Indexed keywords

ADENINE; CYTOSINE; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GUANINE; THYMINE;

3' UNTRANSLATED REGION; ADULT; ARTICLE; AUTOSOMAL RECESSIVE INHERITANCE; CONTROLLED STUDY; DNA POLYMORPHISM; EXON; FEMALE; GENE FREQUENCY; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE; GRAVES DISEASE; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; RECESSIVE GENE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL SIGNIFICANCE; SYSTEMIC LUPUS ERYTHEMATOSUS; THAILAND;

3' UNTRANSLATED REGIONS; ADULT; ALLELES; ASIAN CONTINENTAL ANCESTRY GROUP; CTLA-4 ANTIGEN; EXONS; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GRAVES DISEASE; HETEROZYGOTE; HOMOZYGOTE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; THAILAND; YOUNG ADULT;

EID: 80053034626     PISSN: 0125877X     EISSN: 22288694     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Deapen D, Escalante A, Weinrib L, Horwitz D, Bachman B, Roy-Burman P, et al. A revised estimate of twin concordance in systemic lupus erythematosus. Arthritis Rheum. 1992 Mar;35:311-8.
2. Brix TH, Kyvik KO, Christensen K, Hegedus L. Evidence for a major role of heredity in Graves' disease: a population-based study of two Danish twin cohorts. J Clin Endocrinol Metab. 2001 Feb;86:930-4.
3. Teft WA, Kirchhof MG, Madrenas J. A molecular perspective of CTLA-4 function. Annu Rev Immunol. 2006;24:65-97.
4. Gough SC, Walker LS, Sansom DM. CTLA4 gene polymorphism and autoimmunity. Immunol Rev. 2005 Apr;204:102-15.
5. Pullmann R, Jr., Lukac J, Skerenova M, Rovensky J, Hybenova J, Melus V, et al. Cytotoxic T lymphocyte antigen 4 (CTLA-4) dimorphism in patients with systemic lupus erythematosus. Clin Exp Rheumatol. 1999 Nov-Dec;17:725-9.
6. Ahmed S, Ihara K, Kanemitsu S, Nakashima H, Otsuka T, Tsuzaka K, et al. Association of CTLA-4 but not CD28 gene polymorphisms with systemic lupus erythematosus in the Japanese population. Rheumatology (Oxford). 2001 Jun;40:662-7.
7. Hudson LL, Rocca K, Song YW, Pandey JP. CTLA-4 gene polymorphisms in systemic lupus erythematosus: a highly significant association with a determinant in the promoter region. Hum Genet. 2002 Oct;111:452-5.
8. Fernandez-Blanco L, Perez-Pampin E, Gomez-Reino JJ, Gonzalez A. A CTLA-4 polymorphism associated with susceptibility to systemic lupus erythematosus. Arthritis Rheum. 2004 Jan;50:328-9.
9. Barreto M, Santos E, Ferreira R, Fesel C, Fontes MF, Pereira C, et al. Evidence for CTLA4 as a susceptibility gene for systemic lupus erythematosus. Eur J Hum Genet. 2004 Aug;12:620-6.
10. Torres B, Aguilar F, Franco E, Sanchez E, Sanchez-Roman J, Jimenez Alonso J, et al. Association of the CT60 marker of the CTLA4 gene with systemic lupus erythematosus. Arthritis Rheum. 2004 Jul;50:2211-5.
11. Yanagawa T, Taniyama M, Enomoto S, Gomi K, Maruyama H, Ban Y, et al. CTLA4 gene polymorphism confers susceptibility to Graves' disease in Japanese. Thyroid. 1997 Dec;7:843-6.
12. Allahabadia A, Heward JM, Nithiyananthan R, Gibson SM, Reuser TT, Dodson PM, et al. MHC class II region, CTLA4 gene, and ophthalmopathy in patients with Graves' disease. Lancet. 2001 Sep 22;358:984-5.
13. Kouki T, Gardine CA, Yanagawa T, Degroot LJ. Relation of three polymorphisms of the CTLA-4 gene in patients with Graves' disease. J Endocrinol Invest. 2002 Mar;25:208-13.
14. Furugaki K, Shirasawa S, Ishikawa N, Ito K, Kubota S, Kuma K, et al. Association of the T-cell regulatory gene CTLA4 with Graves' disease and autoimmune thyroid disease in the Japanese. J Hum Genet. 2004;49:166-8.
15. Ban Y, Concepcion ES, Villanueva R, Greenberg DA, Davies TF, Tomer Y. Analysis of immune regulatory genes in familial and sporadic Graves' disease. J Clin Endocrinol Metab. 2004 Sep;89:4562-8.
16. Ban Y, Tozaki T, Taniyama M, Tomita M. Association of a CTLA-4 3' untranslated region (CT60) single nucleotide polymorphism with autoimmune thyroid disease in the Japanese population. Autoimmunity. 2005 Mar;38:151-3.
17. Weng YC, Wu MJ, Lin WS. CT60 single nucleotide polymorphism of the CTLA-4 gene is associated with susceptibility to Graves' disease in the Taiwanese population. Ann Clin Lab Sci. 2005 Summer;35:259-64.
18. Petrone A, Giorgi G, Galgani A, Alemanno I, Corsello SM, Signore A, et al. CT60 single nucleotide polymorphisms of the cytotoxic Tlymphocyte-associated antigen-4 gene region is associated with Graves' disease in an Italian population. Thyroid. 2005 Mar;15:232-8.
19. Han SZ, Zhang SH, Li R, Zhang WY, Li Y. The common-318C/T polymorphism in the promoter region of CTLA4 gene is associated with reduced risk of ophthalmopathy in Chinese Graves' patients. Int J Immunogenet. 2006 Aug;33:281-7.
20. Chen PL, Fann CS, Chang CC, Wu IL, Chiu WY, Lin CY, et al. Family-based association study of cytotoxic T-lymphocyte antigen-4 with susceptibility to Graves' disease in Han population of Taiwan. Genes Immun. 2008 Mar;9:87-92.
21. Tsai ST, Huang CY, Lo FS, Chang YT, Tanizawa T, Chen CK, et al. Association of CT60 polymorphism of the CTLA4 gene with Graves' disease in Taiwanese children. J Pediatr Endocrinol Metab. 2008 Jul;21:665-72.
22. Takahashi M, Kimura A. HLA and CTLA4 polymorphisms may confer a synergistic risk in the susceptibility to Graves' disease. J Hum Genet. 2010 May;55:323-6.
23. Zhao SX, Pan CM, Cao HM, Han B, Shi JY, Liang J, et al. Association of the CTLA4 gene with Graves' disease in the Chinese Han population. PLoS One. 2010;5:e9821.
24. Chistiakov DA, Turakulov RI. CTLA-4 and its role in autoimmune thyroid disease. J Mol Endocrinol. 2003 Aug;31:21-36.
25. Ueda H, Howson JM, Esposito L, Heward J, Snook H, Chamberlain G, et al. Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature. 2003 May 29;423:506-11.
26. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982 Nov;25:1271-7.
27. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988 Feb 11;16:1215.
28. Heward J, Gordon C, Allahabadia A, Barnett AH, Franklyn JA, Gough SC. The A-G polymorphism in exon 1 of the CTLA-4 gene is not associated with systemic lupus erythematosus. Ann Rheum Dis. 1999 Mar;58:193-5.
29. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet. 2007 Sep;81:559-75.
30. Dupont WD, Plummer WD, Jr. Power and sample size calculations. A review and computer program. Control Clin Trials. 1990 Apr;11:116-28.
31. Matsushita M, Tsuchiya N, Shiota M, Komata T, Matsuta K, Zama K, et al. Lack of a strong association of CTLA-4 exon 1 polymorphism with the susceptibility to rheumatoid arthritis and systemic lupus erythematosus in Japanese: an association study using a novel variation screening method. Tissue Antigens. 1999 Dec;54:578-84.
32. Liu MF, Wang CR, Lin LC, Wu CR. CTLA-4 gene polymorphism in promoter and exon-1 regions in Chinese patients with systemic lupus erythematosus. Lupus. 2001;10:647-9.
33. Lee YH, Kim YR, Ji JD, Sohn J, Song GG. Polymorphisms of the CTLA-4 exon 1 and promoter gene in systemic lupus erythematosus. Lupus. 2001;10:601-5.
34. Cho HJ, Chung JH, Kim IS, Kim HJ, Cho SH, Ki CS, et al. Lack of a genetic association between the CTLA-4 gene and Graves' disease in Koreans. Thyroid. 2006 Mar;16:237-41.
35. Kouki T, Sawai Y, Gardine CA, Fisfalen ME, Alegre ML, DeGroot LJ. CTLA-4 gene polymorphism at position 49 in exon 1 reduces the inhibitory function of CTLA-4 and contributes to the pathogenesis of Graves' disease. J Immunol. 2000 Dec 1;165:6606-11.
36. Ban Y, Davies TF, Greenberg DA, Kissin A, Marder B, Murphy B, et al. Analysis of the CTLA-4, CD28, and inducible costimulator (ICOS) genes in autoimmune thyroid disease. Genes Immun. 2003 Dec;4:586-93.
37. Maurer M, Loserth S, Kolb-Maurer A, Ponath A, Wiese S, Kruse N, et al. A polymorphism in the human cytotoxic T-lymphocyte antigen 4 (CTLA4) gene (exon 1 +49) alters T-cell activation. Immunogenetics. 2002 Apr;54:1-8.
38. Ulker M, Yazisiz V, Sallakci N, Avci AB, Sanlioglu S, Yegin O, et al. CTLA-4 gene polymorphism of exon 1(+49 A/G) in Turkish systemic lupus erythematosus patients. Int J Immunogenet. 2009 Aug;36:245-50.
39. Oaks MK, Hallett KM, Penwell RT, Stauber EC, Warren SJ, Tector AJ. A native soluble form of CTLA-4. Cell Immunol. 2000 May 1;201:144-53.
40. Kavvoura FK, Akamizu T, Awata T, Ban Y, Chistiakov DA, Frydecka I, et al. Cytotoxic T-lymphocyte associated antigen 4 gene polymorphisms and autoimmune thyroid disease: a meta-analysis. J Clin Endocrinol Metab. 2007 Aug;92:3162-70.